Botswana vs Democratic Republic of Congo: Average cost of multi drug-resistant tuberculosis treatment
Botswana
900 constant 2022 US$
in 2024
Democratic Republic of Congo
896 constant 2022 US$
in 2024
Botswana rank
53rd
Democratic Republic of Congo rank
54th
Average cost of multi drug-resistant tuberculosis treatment over time
- Botswana
- Democratic Republic of Congo
How they compare
Botswana currently reports 900 constant 2022 US$ against 896 constant 2022 US$ in Democratic Republic of Congo, a difference of 4 constant 2022 US$.
Across all 5 years both countries report, Botswana has been ahead every year.
Botswana ranks 53rd and Democratic Republic of Congo ranks 54th of 92 countries.
Botswana has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Botswana | Democratic Republic of Congo | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 7,278 constant 2022 US$ | 1,332 constant 2022 US$ | 5,946 constant 2022 US$ | Botswana |
| 2020s | 3,700 constant 2022 US$ | 904.5 constant 2022 US$ | 2,796 constant 2022 US$ | Botswana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average cost of multi drug-resistant tuberculosis treatment, Botswana or Democratic Republic of Congo?
- Botswana, at 900 constant 2022 US$ against 896 constant 2022 US$ in Democratic Republic of Congo as of 2024.
- What is the difference in average cost of multi drug-resistant tuberculosis treatment between Botswana and Democratic Republic of Congo?
- 4 constant 2022 US$, with Botswana ahead.
- How many years of comparable data are there for Botswana and Democratic Republic of Congo?
- 5 years are reported by both, from 2017 to 2024.
- How do Botswana and Democratic Republic of Congo rank globally for average cost of multi drug-resistant tuberculosis treatment?
- Botswana ranks 53rd and Democratic Republic of Congo ranks 54th of 92 countries.
- Where does this data come from?
- WHO (2025) – with minor processing by Our World in Data, published as Average cost of multi drug-resistant tuberculosis treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Average cost of drugs spent per patient starting multidrug-resistant tuberculosis treatment, excluding buffer stock.